Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 6,633

Document Document Title
WO/2008/020490A1
Disclosed is a substance having an ability of inhibiting a testosteron-5α-reductase activity, an ability of inhibiting or reducing the proliferation of a cancer cell, an ability of inhibiting a cyclooxygenase, an ability of inhibiting a...  
WO/2008/019784A2
Disclosed are novel avermectin derivatives of formula (I), wherein -C22R1-A-C23R2, R3, R4, and R5 have the meanings indicated in the description, methods for producing said substances, the use thereof for controlling animal pests, novel ...  
WO/2008/019240A2
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof, which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions com...  
WO/2008/017696A1
Macrolide compounds of formula I: with PDF4 inhibiting activity are described, wherein R1 is a residue -Y-X-Q; Y is S, SO or SO2; X is a bond or a linear group consisting of hydrogen atoms and with up to 9 atoms selected from C, N, O and...  
WO/2008/016105A1
Disclosed are: a highly safe pharmaceutical composition for the prevention and/or treatment of a bone disease; and a pharmaceutical preparation, a health food or a functional food comprising the composition. An arylheptanoid compound rep...  
WO/2008/016132A1
Disclosed is a benzyl phenyl glucopyranoside derivative having excellent inhibitory effect on human SGLT1 and/or SGLT2 activity. Specifically disclosed is a compound represented by the general formula (I) or a pharmacologically acceptabl...  
WO/2008/014722A1
Prenyl flavonoids, their preparation and use. The prenyl flavonoids are shown by formula I,in which ring A is five or six carbon ring glucide, or disaccharide; R is substitute of hydroxy on ring A selected from H,COCmH2m+1(m is natural n...  
WO/2007/067281A3
A method for demethylating the 3'-dimethylamino group of erythromycin compounds.  
WO/2008/014221A2
The present invention discloses compounds of formulae (I) and (II) or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical composi...  
WO/2008/012343A2
This invention relates to a method for making macrolides, and, in particular, to a method for making optionally substituted 20,23-dipiperidinyl-5-O-mycaminosyl- tylonolide and derivatives thereof, as well as uses of macrolides to make me...  
WO/2008/007388A1
The present invention relates to the process for the preparation of compounds of formula (I) or its pharmaceutically acceptable salts; wherein R is formula (A).  
WO/2008/007027A1
The invention relates to new 5-thioxylose compounds, preferably 5-thioxylopyranose type derivatives, and the method of preparation thereof and their use as active ingredient for drugs, in particular intended for treatment or prevention o...  
WO/2008/007684A1
In the process of investigating a mechanism by which a tree growing in a cold climate maintains cellular water in a liquid state at a low temperature, the inventor conducted an investigation to identify a causative substance of that. As ...  
WO/2007/029265A3
The present invention discloses a process for preparing Clarithromycin, comprising selectiviely methylating a 2'I4"-O-bis(trimethylsilyl)erythromycin A 9-[O-(1-methoxy-1- methylethyl)oxime] of formula (II) with methylating agent comprisi...  
WO/2007/148697A1
Disclosed is an inhibitor of the expression of a nuclear transcription factor AP-1, which is excellent in safety and inhibitory activity on the expression of the nuclear transcription factor AP-1. The inhibitor is characterized by compri...  
WO/2007/049296A3
The present invention relates to novel substantially amorphous Telithromycin and its process of preparation.  
WO/2007/144200A1
The present invention relates to a process for the coupling of two molecules by means of a Diels-Alder reaction with an inverse electron requirement, which comprises the following steps: reaction of (a) a triazine or tetrazine having one...  
WO/2007/125562A3
The present invention concerns a method for the preparation and the use of an extract enriched of cyanidin-3-O-β-glucopyranoside and of its derivatives obtained from fruits or vegetables containing the aforementioned anthocyanin, and fo...  
WO/2007/141513A1
The invention provides coumarin compounds, in particular glycosidic coumarin compounds, useful in the treatment of dermatophyte fungal infections.  
WO/2007/143507A2
The present disclosure is directed to novel macrolide antibiotics of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof; and the chemical syntheses and medical uses of these novel macrolide antibiotics for the treatme...  
WO/2007/029266A3
The invention relates to a process for preparing θ-Deoxo-θa-aza-θa-homoerythromycin A of formula (III), which is an intermediate in the preparation of Azithromycin dihydrate.  
WO/2007/015265A3
A process for preparing 6,9-lmino ether from Erythromycin thiocyanate without isolating Erythromycin base and Erythromycin oxime and Beckmann's rearrangement of erythromycin oxime is carried in the presence biphasic solvent system compri...  
WO/2007/060518A3
Provided herein are ketolide derivatives, which can be used as antibacterial agents. Compounds described herein can be used for treating or preventing conditions caused by or contributed to by gram positive, gram negative or anaerobic ba...  
WO/2007/069264A3
A method of testing the purity of a sample of Telithromycin or a pharmaceutical dosage form comprising Telithromycin, which method comprises assaying the said sample for the presence of compound A, B and D, wherein compound A is represen...  
WO/2007/086884A3
The invention describes novel organic nitric oxide donor salts of a antimicrobial . compounds, and novel compositions and kits comprising at least one organic nitric oxide donor salt of an antimicrobial compound, and, optionally, at leas...  
WO/2007/056525A3
The invention relates to high affinity Siglec ligands that are useful for isolating cells that express Siglecs and for delivering agents to cells that express Siglecs. In one embodiment, the invention provides a method for treating cance...  
WO/2007/132937A1
Seven kinds of novel antibiotics could be produced by culturing a strain named Microbispora sp. A34030 strain (deposited under the accession number of FERM BP-10505 under Budapest Treaty) which had been isolated from a soil sample. The s...  
WO/2007/129646A1
Compounds represented by the formula (I): (I) and the formula (VI): (VI) have an action of inhibiting the production of MMP-9, and hence they are useful as a preventive agent and a therapeutic agent for oncogenic angiogenesis, chronic rh...  
WO/2007/129668A1
Disclosed is a novel pyrazolyl 5-thio-β-D-glucopyranoside compound which can inhibit the SGLT1 activity selectively and can prevent the absorption of glucose through the digestive tract, thereby controlling the IGT (impaired glucose tol...  
WO/2007/125562A2
The present invention concerns a method for the preparation and the use of an extract enriched of cyanidin-3-O-β-glucopyranoside and of its derivatives obtained from fruits or vegetables containing the aforementioned anthocyanin, and fo...  
WO/2005/025490A3
A novel family of cyclic polyene natural products isolated from marine actinomycete strain CNQ 140 is provided. This novel strain of actinomycetes was obtained from a previously unstudied population of marine actinomycetes that reside in...  
WO/2007/119754A1
[PROBLEMS] To provide a novel agent for the prevention or treatment of leukemia. [MEANS FOR SOLVING PROBLEMS] Disclosed is an agent for the prevention or treatment of leukemia, which comprises at least a composition derived from an olive...  
WO/2007/116015A1
The present invention relates to novel lactose-derived compounds of general formula (I) and to their use as agents for stimulating the immune system of the skin and/or as immunoregulators, and for preparing a composition containing a cos...  
WO2006100413A9
The invention relates to novel compounds derived from 5-thioxylose, preferably 5-thioxylopyranose-type derivatives, and to the preparation method thereof and the use of same as an active principle in medicaments which are intended, for e...  
WO/2007/112473A1
A process for purifying a crude α- or a crude β-anomer of a 2,2'-difluoronucleoside, or a derivative thereof, which process includes: providing: an organic or inorganic acid; an amount of crude α- or β-anomer of a 2,2'-difluoronucleo...  
WO/2007/114304A1
Disclosed is a benzene production inhibitor which can inhibit the production of harmful benzene from a benzoic acid-containing product and is innoxious to a human body. The inhibitor comprises flavonol and/or a glycoside thereof or a com...  
WO/2007/109804A2
The present invention relates to extracts of cinnamon species plant material prepared by supercritical CO2 extractions methods.  
WO/2007/089149A3
This invention relates to novel analogs of the DNA-binding alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and their conjugates. The conjugates are de...  
WO/2007/109600A2
The present invention relates to extracts of elder species plant material prepared by supercritical CO2 extractions methods, methods of treating viruses in a subject and methods of inhibiting viral infections in cells thereof.  
WO/2007/063335A3
The invention provides a salt of amphotericin B and meglumine in which the molar ratio of amphotericin B to meglumine is about 1:1.  
WO/2007/105547A1
The invention provides methods for improving the absorbability and antioxidant ability of myricetin in the body. Either of the methods can be achieved by binding one or a plurality of glucosyl groups to the oxygen atom at the 3 or 3' pos...  
WO/2007/104242A1
The invention has disclosed 1,2,3-trihydroxy benzene and its derivatives or pharmaceutically acceptable salts of formula I for zinc ion metal-protease inhibition. These compounds are used for selective depressants of zinc ion metal-prote...  
WO/2007/102438A1
[PROBLEMS] To provide: a fractionation method for extracting an ingredient, particularly a pharmacologically active ingredient such as an iridoid compound, from an Eucommia ulmoides oliver leaf with good efficiency; a fractionation produ...  
WO/2007/102439A1
[PROBLEMS] To provide: a fractionation method for extracting an ingredient, particularly a pharmacologically active ingredient such as an iridoid compound, from an Eucommia ulmoides oliver leaf with good efficiency; a fractionation produ...  
WO/2007/099915A1
It is intended to provide a highly safe antiviral agent originating in a plant, a food and a drink containing this antiviral agent and a medicine containing this antiviral agent as the active ingredient. Namely, an antiviral agent charac...  
WO/2007/096137A1
The present invention provides new polyene macrolide derivatives which show very low toxicity while retaining high antifungal activity as compared with amphotericin B (AmB). These polyene macrolide derivatives comprise a polyene macrolid...  
WO/2007/060618A3
The present invention provides macrolide derivatives, which can be used as antibacterial agents. Compounds described herein can be used for treating or preventing conditions caused by or contributed to by gram-positive, gram-negative or ...  
WO/2007/091393A1
[PROBLEMS] To provide a compound which has a novel structure and is effective against an influenza bacterium and an erythromycin-resistant bacterium (e.g., an erythromycin-resistant pneumococcal or streptococcal bacterium), as well as a ...  
WO/2007/089149A2
This invention relates to novel analogs of the DNA-binding alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and their conjugates. The conjugates are de...  
WO/2007/083594A1
It is intended to provide a laxative with a gentle cathartic action and reduced diarrhea episodes and a food containing the same. A laxative containing genkwanin 5-O-β-primeveroside as an active ingredient. A laxative containing iriflop...  

Matches 501 - 550 out of 6,633